0001203311-14-000020.txt : 20140224 0001203311-14-000020.hdr.sgml : 20140224 20140224192554 ACCESSION NUMBER: 0001203311-14-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140220 FILED AS OF DATE: 20140224 DATE AS OF CHANGE: 20140224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRACHMAN JONATHAN G CENTRAL INDEX KEY: 0001588467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 14638447 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-20 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001588467 DRACHMAN JONATHAN G 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 CMO & EVP, R & D Common Stock 2014-02-20 4 S 0 1241.0 53.25 D 48670 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Drachman on September 16, 2013. Amount of securities beneficially owned following reported transactions includes 48,500 Restricted Stock Units subject to vesting. Jonathan G. Drachman 2014-02-24